Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Norris Cotton Cancer Center-North
mi
from
Saint Johnsbury, VT
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Norris Cotton Cancer Center-North
mi
from
Saint Johnsbury, VT
Click here to add this to my saved trials
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Francis Hospital
mi
from
Federal Way, WA
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Francis Hospital
mi
from
Federal Way, WA
Click here to add this to my saved trials
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
EvergreenHealth Medical Center
mi
from
Kirkland, WA
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
EvergreenHealth Medical Center
mi
from
Kirkland, WA
Click here to add this to my saved trials
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Virginia Mason Medical Center
mi
from
Seattle, WA
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
PeaceHealth Southwest Medical Center
mi
from
Vancouver, WA
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
PeaceHealth Southwest Medical Center
mi
from
Vancouver, WA
Click here to add this to my saved trials
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
A Phase II Study of 131I-labeled Metaiodobenzylguanidine (MIBG) for Treatment of Patients With Metastatic or Unresectable Pheochromocytoma and Related Tumors
Status: Enrolling
Updated:  12/31/1969
UCSF
mi
from
San Francisco, CA
A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors
A Phase II Study of 131I-labeled Metaiodobenzylguanidine (MIBG) for Treatment of Patients With Metastatic or Unresectable Pheochromocytoma and Related Tumors
Status: Enrolling
Updated: 12/31/1969
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Protocol ATI001-102 Expansion Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Protocol ATI001-102 Expansion Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Protocol ATI001-102 Expansion Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Northwestern Memorial Hospital
mi
from
Chicago, IL
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Protocol ATI001-102 Expansion Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Protocol ATI001-102 Expansion Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Protocol ATI001-102 Expansion Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Protocol ATI001-102 Expansion Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma
Status: Enrolling
Updated:  12/31/1969
NYU Langone Health
mi
from
New York, NY
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Protocol ATI001-102 Expansion Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma
Status: Enrolling
Updated: 12/31/1969
NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas
Status: Enrolling
Updated:  12/31/1969
Hematology-Oncology Associates of Illinois
mi
from
Chicago, IL
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas
Status: Enrolling
Updated: 12/31/1969
Hematology-Oncology Associates of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas
Status: Enrolling
Updated:  12/31/1969
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas
Status: Enrolling
Updated: 12/31/1969
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas
Status: Enrolling
Updated:  12/31/1969
University Cancer Center at University of Washington Medical Center
mi
from
Seattle, WA
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas
Status: Enrolling
Updated: 12/31/1969
University Cancer Center at University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
Phase II Evaluation Temozolomide and Farnesyl Transferase Inhibitor (SCH66336) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
U.T.M.D. Anderson Cancer Center
mi
from
Houston, TX
Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
Phase II Evaluation Temozolomide and Farnesyl Transferase Inhibitor (SCH66336) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
U.T.M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors
High Dose I-131 Metaiodobenzylguanidine (MIBG) Therapy for Metastatic Neuroendocrine Tumors
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors
High Dose I-131 Metaiodobenzylguanidine (MIBG) Therapy for Metastatic Neuroendocrine Tumors
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas
Phase I Trial of Intratumoral Injection of DTI-015 for Recurrent Malignant Gliomas
Status: Enrolling
Updated:  12/31/1969
UT MD Anderson Cancer Center
mi
from
Houston, TX
Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas
Phase I Trial of Intratumoral Injection of DTI-015 for Recurrent Malignant Gliomas
Status: Enrolling
Updated: 12/31/1969
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Vioxx and Radiation Therapy for Brainstem Glioma
Phase I Study of Vioxx and Radiation Therapy for Brainstem Glioma
Status: Enrolling
Updated:  12/31/1969
UT MD Anderson Cancer Center
mi
from
Houston, TX
Study of Vioxx and Radiation Therapy for Brainstem Glioma
Phase I Study of Vioxx and Radiation Therapy for Brainstem Glioma
Status: Enrolling
Updated: 12/31/1969
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center, Department of Neurological Surgery
mi
from
Nashville, TN
Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center, Department of Neurological Surgery
mi
from
Nashville, TN
Click here to add this to my saved trials
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated:  12/31/1969
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated: 12/31/1969
H. Lee Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated:  12/31/1969
Kentuckaina Cancer Institute
mi
from
Louisville, KY
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated: 12/31/1969
Kentuckaina Cancer Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center, Department of Neurological Surgery
mi
from
Nashville, TN
Risk Factors for Adult-Onset Brain Tumors
Genetic Epidemiology of Adult Brain Tumors
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center, Department of Neurological Surgery
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPSC001 in NETs
An International, Multicenter, Open-label Study to Evaluate Safety, Tolerability, Biodistribution, Dosimetry and Preliminary Efficacy of 177Lu-OPS201 for the Therapy of Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated:  12/31/1969
City of Hope, Department of Nuclear Medicine
mi
from
Duarte, CA
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPSC001 in NETs
An International, Multicenter, Open-label Study to Evaluate Safety, Tolerability, Biodistribution, Dosimetry and Preliminary Efficacy of 177Lu-OPS201 for the Therapy of Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated: 12/31/1969
City of Hope, Department of Nuclear Medicine
mi
from
Duarte, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPSC001 in NETs
An International, Multicenter, Open-label Study to Evaluate Safety, Tolerability, Biodistribution, Dosimetry and Preliminary Efficacy of 177Lu-OPS201 for the Therapy of Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated:  12/31/1969
Peter MacCallum Cancer Centre, Molecular Imaging and Targeted Therapeutics Laboratory
mi
from
East Melbourne,
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPSC001 in NETs
An International, Multicenter, Open-label Study to Evaluate Safety, Tolerability, Biodistribution, Dosimetry and Preliminary Efficacy of 177Lu-OPS201 for the Therapy of Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated: 12/31/1969
Peter MacCallum Cancer Centre, Molecular Imaging and Targeted Therapeutics Laboratory
mi
from
East Melbourne,
Click here to add this to my saved trials
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPSC001 in NETs
An International, Multicenter, Open-label Study to Evaluate Safety, Tolerability, Biodistribution, Dosimetry and Preliminary Efficacy of 177Lu-OPS201 for the Therapy of Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated:  12/31/1969
MD Anderson Cancer Center, Department of Nuclear Medicine
mi
from
Houston, TX
Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPSC001 in NETs
An International, Multicenter, Open-label Study to Evaluate Safety, Tolerability, Biodistribution, Dosimetry and Preliminary Efficacy of 177Lu-OPS201 for the Therapy of Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated: 12/31/1969
MD Anderson Cancer Center, Department of Nuclear Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated:  12/31/1969
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated: 12/31/1969
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated:  12/31/1969
Children's Memorial Hospital
mi
from
Chicago, IL
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated: 12/31/1969
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated:  12/31/1969
Children's Hospitals and Clinics
mi
from
Minneapolis, MN
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated: 12/31/1969
Children's Hospitals and Clinics
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated:  12/31/1969
Children's Hospitals and Clinics
mi
from
Saint Paul, MN
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated: 12/31/1969
Children's Hospitals and Clinics
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated:  12/31/1969
Washington University Medical Center
mi
from
Saint Louis, MO
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated: 12/31/1969
Washington University Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated:  12/31/1969
Children's Medical Center
mi
from
Dayton, OH
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
Status: Enrolling
Updated: 12/31/1969
Children's Medical Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma
A Pilot Study Using Amide Proton Transfer (APT) Magnetic Resonance Imaging to Distinguish Tumor Bearing Cancerous Tissue From Normal Tissue in Patients With Glioma.
Status: Enrolling
Updated:  12/31/1969
SKCCC at Johns Hopkins
mi
from
Baltimore, MD
Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma
A Pilot Study Using Amide Proton Transfer (APT) Magnetic Resonance Imaging to Distinguish Tumor Bearing Cancerous Tissue From Normal Tissue in Patients With Glioma.
Status: Enrolling
Updated: 12/31/1969
SKCCC at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy Using [F18] Fluorothymidine (FLT) As a Marker of Proliferation in Patients With Primary Brain Tumors
Status: Enrolling
Updated:  12/31/1969
University Cancer Center at University of Washington Medical Center
mi
from
Seattle, WA
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy Using [F18] Fluorothymidine (FLT) As a Marker of Proliferation in Patients With Primary Brain Tumors
Status: Enrolling
Updated: 12/31/1969
University Cancer Center at University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Gene Therapy in Treating Patients With Primary Brain Tumors
A PHASE I TRIAL OF HSV-TK ADENOVIRUS GENE THERAPY FOR PRIMARY BRAIN TUMORS
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania Cancer Center
mi
from
Philadelphia, PA
Gene Therapy in Treating Patients With Primary Brain Tumors
A PHASE I TRIAL OF HSV-TK ADENOVIRUS GENE THERAPY FOR PRIMARY BRAIN TUMORS
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT/REFRACTORY SOLID TUMORS WITH HIGH DOSE ETOPOSIDE AND CARBOPLATIN PLUS ESCALATING DOSE CYCLOPHOSPHAMIDE, FOLLOWED BY HEMATOPOIETIC RESCUE USING AUTOLOGOUS CD34+ SELECTED BLOOD STEM CELLS: A PILOT STUDY
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Oncology Center
mi
from
Baltimore, MD
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT/REFRACTORY SOLID TUMORS WITH HIGH DOSE ETOPOSIDE AND CARBOPLATIN PLUS ESCALATING DOSE CYCLOPHOSPHAMIDE, FOLLOWED BY HEMATOPOIETIC RESCUE USING AUTOLOGOUS CD34+ SELECTED BLOOD STEM CELLS: A PILOT STUDY
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Oncology Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Status: Enrolling
Updated:  9/19/2006
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Status: Enrolling
Updated: 9/19/2006
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
Status: Enrolling
Updated:  12/18/2007
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
Status: Enrolling
Updated: 12/18/2007
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
Status: Enrolling
Updated:  12/18/2007
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
Status: Enrolling
Updated: 12/18/2007
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase I Dose Escalation Study for Patients With Recurrent Malignant Gliomas
A Phase I Dose Escalation Study of Vandetanib (ZactimaTM , ZD6474) With Hypofractionated Stereotactic Radiotherapy in Patients With Recurrent Malignant Gliomas
Status: Enrolling
Updated:  7/23/2008
University of Colorado Cancer Center - Anschutz Cancer Pavilion
mi
from
Aurora, CO
A Phase I Dose Escalation Study for Patients With Recurrent Malignant Gliomas
A Phase I Dose Escalation Study of Vandetanib (ZactimaTM , ZD6474) With Hypofractionated Stereotactic Radiotherapy in Patients With Recurrent Malignant Gliomas
Status: Enrolling
Updated: 7/23/2008
University of Colorado Cancer Center - Anschutz Cancer Pavilion
mi
from
Aurora, CO
Click here to add this to my saved trials
Targeting Inattention in Childhood Cancer Survivors (TRICCS)
TRICCS: Targeting Inattention in Childhood Cancer Survivors
Status: Enrolling
Updated:  8/13/2008
Duke Univ Med Ctr
mi
from
Durham, NC
Targeting Inattention in Childhood Cancer Survivors (TRICCS)
TRICCS: Targeting Inattention in Childhood Cancer Survivors
Status: Enrolling
Updated: 8/13/2008
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
Status: Enrolling
Updated:  3/9/2009
Yale University School of Medicine
mi
from
New Haven, CT
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
Status: Enrolling
Updated: 3/9/2009
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme
A Phase II Protocol for the Use of Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  5/20/2009
The Preston Robert Tisch Brain Tumor Center
mi
from
Durham, NC
Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme
A Phase II Protocol for the Use of Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 5/20/2009
The Preston Robert Tisch Brain Tumor Center
mi
from
Durham, NC
Click here to add this to my saved trials
Brain Tumor Treatment Satisfaction Survey
Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers
Status: Enrolling
Updated:  9/17/2009
Methodist University Hospital
mi
from
Memphis, TN
Brain Tumor Treatment Satisfaction Survey
Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers
Status: Enrolling
Updated: 9/17/2009
Methodist University Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Hepatoblastoma Biology Study and Tissue Bank
Hepatoblastoma Biology Study and Tissue Bank
Status: Enrolling
Updated:  10/22/2009
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Hepatoblastoma Biology Study and Tissue Bank
Hepatoblastoma Biology Study and Tissue Bank
Status: Enrolling
Updated: 10/22/2009
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
In Vivo Confocal Microscopy Tumor Atlas Study
In Vivo Confocal Microscopy Tumor Atlas Study
Status: Enrolling
Updated:  11/10/2009
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
In Vivo Confocal Microscopy Tumor Atlas Study
In Vivo Confocal Microscopy Tumor Atlas Study
Status: Enrolling
Updated: 11/10/2009
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated:  12/29/2009
Sloan-Kettering Institute for Cancer Research
mi
from
New York, NY
Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme
Status: Enrolling
Updated: 12/29/2009
Sloan-Kettering Institute for Cancer Research
mi
from
New York, NY
Click here to add this to my saved trials